Physiological 68Ga-RM2 uptake in patients with biochemically recurrent prostate cancer: an atlas of semi-quantitative measurements.
Lucia BarattoHeying DuanRiccardo LaudicellaAkira ToriiharaNegin HatamiValentina FerriAndrei H IagaruPublished in: European journal of nuclear medicine and molecular imaging (2019)
68Ga-RM2 has been mostly evaluated for PC detection, but it can be used for other tumors overexpressing GRPR such as breast cancer. This atlas of normal biodistribution and SUV measurements in healthy tissues will help physicians distinguish between physiological vs. pathological uptake, as well as potentially assist with planning future studies using GRPR targeting radiopharmaceuticals.